Eric Berger
Associé,
À propos de Eric
Expertise
Eric Berger is a member of Bain’s Healthcare & Life Sciences and Private Equity practices with more than 10 years of consulting experience.
Eric advises clients across a range of industries, with a focus in private equity funds as well as healthcare payers and services and biotech / pharma. He has additional experience in industrial goods and services and consumer packaged goods.
He holds expertise in topics related to commercial due diligence, business unit strategy, operating model, organization design, pricing, brand strategy and mergers & acquisitions.
Prior to joining Bain in 2011, Eric worked for a small consulting firm in Boston focused on the pharmaceutical, biotech and medical device industries. Previously, he was a researcher in organic chemistry at Harvard University. Eric has published in Science and the Journal of the American Chemical Society and was awarded a grant from the Howard Hughes Medical Institute and the Jean Dreyfus Boissevain scholarship.
Eric earned an MBA from MIT Sloan School of Management. He holds a BA cum laude and MA in chemistry from Harvard University.
Recent Insights
- “Inside Bain’s 2023 Healthcare Provider IT Report,” Webinar, 20 septembre 2023
- “2023 Healthcare Provider IT Report: Doubling Down on Innovation,” Etude, 12 septembre 2023
- “Beyond Hype: Getting the Most Out of Generative AI in Healthcare Today,” Etude, 7 août 2023
- “Provider Information Technology: Mind the Gap,” Global Healthcare Private Equity Report, 10 avril 2023, Rapport
- “Payers: After Two Bumper Years, Healthcare Private Equity Payer Buyouts Grew Scarce ,” Global Healthcare Private Equity Report, 10 avril 2023, Rapport